Australia, Jan. 10 -- Teva Pharmaceuticals International Gmbh, owns the trademark (2454074) for 'OLZEBY' till May 29, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations, namely, anti-psychotics]
Type of Mark: Word
Date of Acceptance: July 17, 2024
Registration Advertised: Jan. 9
For further details contact Davies Collison Cave Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2454074.
Disclaimer: Curated by HT Syndication.
